Blis Technologies takes $350k provision over safe but ugly product, affirms revenue forecast

Blis Technologies takes $350k provision over safe but ugly product, affirms revenue forecast
Paul McBeth
By Paul McBeth Nov. 4 (BusinessDesk) - Blis Technologies, the probiotics product maker, has taken a $350,000 provision for a speckled discolouration of a lozenge product line in Europe, but has retained its expectations to double annual revenue, saying the product is safe and no other markets are affected. The Dunedin-based company launched an investigation into the product line this week, halting trading in its shares, after it found a quality problem in one of its product lines. It said today a particular formulation for one European cu...